⌘K

Login Start Free

Home/Filings/4/0001144204-16-126314

4//SEC Filing

Caladrius Biosciences, Inc. 4

Accession 0001144204-16-126314

$LSTACIK 0000320017operating

View on SEC.gov Company Profile

Filed

Sep 29, 8:00 PM ET

Accepted

Sep 30, 4:32 PM ET

Size

5.9 KB

Accession

0001144204-16-126314

Insider Transaction Report

Form 4

Period: 2016-09-29

Caladrius Biosciences, Inc.CLBS

See Remarks

Transactions

Award
Stock Option
2016-09-29+20,894→ 20,894 total
Exercise: $4.77From: 2016-09-29Exp: 2026-09-29→ Common Stock (20,894 underlying)

Footnotes (1)

[F1]These stock options were granted upon the Company's Compensation Committee approval on September 29, 2016, in consideration of the unpaid portion of the reporting person's discretionary 2015 target bonus.

Documents

1 file

4
v449789_4.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

Caladrius Biosciences, Inc.

CIK 0000320017

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0000320017

Filing Metadata

Form type: 4
Filed: Sep 29, 8:00 PM ET
Accepted: Sep 30, 4:32 PM ET
Size: 5.9 KB

View on SEC.gov